↓ Skip to main content

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 3,273)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
19 news outlets
twitter
30 tweeters
patent
1 patent

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Published in
Journal for Immunotherapy of Cancer, April 2021
DOI 10.1136/jitc-2021-002371
Pubmed ID
Authors

Brendan D Curti, Yoshinobu Koguchi, Rom S Leidner, Annah S Rolig, Elizabeth R Sturgill, Zhaoyu Sun, Yaping Wu, Venkatesh Rajamanickam, Brady Bernard, Ian Hilgart-Martiszus, Christopher B Fountain, George Morris, Noriko Iwamoto, Takashi Shimada, ShuChing Chang, Peter G Traber, Eliezer Zomer, J Rex Horton, Harold Shlevin, William L Redmond

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 30 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 8 17%
Student > Master 7 15%
Student > Bachelor 4 9%
Student > Ph. D. Student 4 9%
Other 3 7%
Other 2 4%
Unknown 18 39%
Readers by discipline Count As %
Unspecified 8 17%
Medicine and Dentistry 7 15%
Biochemistry, Genetics and Molecular Biology 6 13%
Agricultural and Biological Sciences 3 7%
Immunology and Microbiology 2 4%
Other 1 2%
Unknown 19 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 151. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2023.
All research outputs
#256,022
of 24,417,958 outputs
Outputs from Journal for Immunotherapy of Cancer
#47
of 3,273 outputs
Outputs of similar age
#7,665
of 431,085 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 138 outputs
Altmetric has tracked 24,417,958 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,273 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,085 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.